Practice Advisories

Practice Advisories

Practice Advisories (PAs) are brief, urgent reports that are intended to provide rapid updates and guidance to assist the membership in decision-making areas of clinical care and patient safety. Practice Advisories are written by the Publications Committee and approved by the Board of Directors. PAs are reviewed for relevancy/accuracy by the Publications Committee on a yearly basis and will be retired if a subsequent guidance document is published on the topic.

 

Removal of Black Box Warning Label from Topical Low-Dose Vaginal Estrogen Products (December 2025)

Possible drug induced retinal maculopathy secondary to long-term use of pentosan polysulfate sodium (Elmiron) (August 2020)